The bioindustry is another emerging leading industry after the information industry. Human society has entered a new era of biological economy. The Chinese government formulated the "Eleventh Five-Year Plan" for the bioindustry for the first time in 2007, drawing a grand blueprint for the biological industry. In general, China's bioindustry is still in its infancy, and the basic research of industrial development lags far behind that of developed countries. After more than 10 years of development, China's bioindustry has made great progress, but the relevant achievements still fall short of expectations. In the biological industry, the biopharmaceutical industry is undoubtedly a bright pearl. But at present, the development speed of biopharmaceutical industrialization in China is also relatively slow. Except for Beijing, Shanghai and Shenzhen, the number of biopharmaceutical enterprises in other regions is small, and they often fight alone, lacking of echo and cooperation within the region, and it is difficult to achieve the macro goal of industrialization development. The biopharmaceutical industry has received a lot of attention in recent years and has even been regarded by some as the golden key to solving human diseases. At present, the country attaches great importance to the development of the biopharmaceutical industry and has issued a series of policies to assist and support the biopharmaceutical industry. However, there are still some problems in the development of biopharmaceutical industrialization, such as insufficient innovation, insignificant industrial effect and weak independent research and development capability. How to promote the industrialization of biopharmaceutical industry has also become a topic of common concern for academics and governments. Based on this thinking, this article will study the influencing factors of Shenzhen's biopharmaceutical industrialization, analyze which factors can have a significant impact on the development of biopharmaceutical industrialization, and also analyze the specific action mechanism of these influencing factors. From the perspective of research methods, this paper relies on the Likert five-level evaluation scale to conduct a questionnaire survey on Shenzhen's biopharmaceutical industry and relevant government departments, and rely on data processing software such as SPSS to process and analyze the collected data information. This article hopes that through research, we can find a way to promote the development of Shenzhen's biopharmaceutical industrialization and provide some experience for the development of biopharmaceutical industrialization in other regions of China.